Disc Medicine, Inc. Increase (Decrease) in Other Operating Assets
Disc Medicine, Inc. (IRON) reported Increase (Decrease) in Other Operating Assets of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2024-03-21
- Disc Medicine, Inc. increase (decrease) in other operating assets for the quarter ending 2023-12-31 was $0.00.
- Disc Medicine, Inc. increase (decrease) in other operating assets for the quarter ending 2023-09-30 was $0.00.
- Disc Medicine, Inc. increase (decrease) in other operating assets for the quarter ending 2023-06-30 was $0.00.
- Disc Medicine, Inc. increase (decrease) in other operating assets for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Disc Medicine, Inc. increase (decrease) in other operating assets for fiscal 2023 was $0.00.
- Disc Medicine, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$64.00K, a 200.00% decline from fiscal 2021.
- Disc Medicine, Inc. increase (decrease) in other operating assets for fiscal 2021 was $64.00K.
- Disc Medicine, Inc. increase (decrease) in other operating assets for fiscal 2020 was -$2.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | $0.00 derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | -$128.00K derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | -$128.00K derived: sum of 3 quarters · filed 2024-03-21 | -$64.00K 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$128.00K derived: sum of 2 quarters · filed 2023-11-09 | -$64.00K 10-Q · filed 2023-11-09 | -$39.00K 10-Q · filed 2022-11-10 | -$232.00K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$64.00K 10-Q · filed 2023-08-11 | -$33.00K 10-Q · filed 2022-08-11 | -$232.00K derived: sum of 3 quarters · filed 2023-08-11 | -$559.00K derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $64.00K 10-Q · filed 2023-05-15 | -$20.00K 10-Q · filed 2022-05-06 | -$104.00K derived: sum of 2 quarters · filed 2023-05-15 | -$431.00K derived: sum of 3 quarters · filed 2023-05-15 | -$97.00K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$495.00K derived: sum of 2 quarters · filed 2023-03-31 | -$161.00K derived: sum of 3 quarters · filed 2023-03-31 | $64.00K 10-K · filed 2023-03-31 | $237.00K 10-K · filed 2022-03-10 | |||
| 2021-09-30 | -$327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $7.00K derived: sum of 2 quarters · filed 2022-11-10 | $232.00K 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | $334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $559.00K 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | $225.00K 10-Q · filed 2022-05-06 | |||||||
| 2020-12-31 | -$2.00K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |